Anthropic Buys One-Person Biotech Mithril, Starts Own Drug Discovery

Anthropic acquires one-person biotech startup that used Claude to develop promising muscular dystrophy treatment in 18 months - Tech Startups

Anthropic has acquired a biotech startup with just one full-time employee that used Claude AI to develop an experimental treatment for a rare childhood muscle disease in under 18 months, producing early results in mice showing improved muscle strength and […] The post Anthropic acquires one-person biotech startup that used Claude to develop promising muscular dystrophy treatment in 18 months first appeared on Tech Startups.

Anthropic buys one-person biotech Mithril, starts own drug discovery

Anthropic has acquired Mithril Medicine, a one-person company developing treatments for two rare forms of muscular dystrophy. The company announced the deal in a blog post on Tuesday. Mithril’s founder, Cody Tranbarger, has joined Anthropic. It did not disclose the terms, The Information reported. Anthropic said it has also begun drug discovery efforts of its […] This story continues at The Next Web

Anthropic speeds up drug discovery as Claude spots issues humans miss, cuts review time by 89%

Anthropic has entered drug discovery by acquiring Mithril Medicine and announcing six research partnerships. Claude's preclinical results point to faster reviews, regulatory drafting and treatment design.

Anthropic Acquires One-Person Drug Discovery Startup Mithril Medicine Founded By Cody Tranbarger

Just three years into the AI revolution, one-person startups seem to be truly here. Anthropic has acquired Mithril Medicine, a one-person biotech developing...